Ethical Considerations of Incorporating GLP-1 Medications in Noom’s Weight-Loss Program Medical Ethics Overview: The use, promotion, and advertisement of any drug, including medications, should always be approached with medical ethical considerations. While drugs can provide therapeutic benefits, it is essential to recognize that any substance, if used improperly or without proper medical guidance, can have…
The new study finds that Pfizer’s oral diabetes drug (Danuglipron) performs better than Novo Nordisk’s injection in terms of weight loss The overview of the company: Pfizer Inc. is a leading global pharmaceutical company headquartered in New York City. With a focus on research, development, and marketing of prescription drugs, vaccines, and consumer healthcare products,…
Wegovy supply constraints only affect the USA market Due to high demand, the giant manufacturer Novo Nordisk has temporarily cut the wegovy supply for the starter doses of its popular weight-loss drug Wegovy by 50% due to wegovy supply constraints Novo Nordisk is a Danish multinational pharmaceutical giant company that specializes in the production and…
Eli Lilly is seeking approval from the FDA for an antidiabetes medication called Tirzepatide as an Antiobese medication According to a new study, which the drug maker sponsored, subjects that took the medication, known under the brand name Mounjaro(Tirzepatide), for 72 weeks lost 15.7% of their body weight when utilizing it alongside diet and exercise….
Mounjaro an Antidiabetic Drug proves to be effective in weight loss as claimed by Eli Lilly the giant pharmaceutical The drug Mounjaro, which is used to treat diabetes, has been found to be effective for weight loss in two large studies. The drug, which is likely to be approved for weight loss later this year,…
Is obesity considered a treatable condition? Overview A global analysis in The Lancet reveals over one billion people worldwide are obese, with rates quadrupling in children since 1990 and doubling in adults. Conducted by the NCD-RisC in collaboration with LSHTM and Imperial College London, the study highlights concerning trends. Professor Martin Mckee warns of alarming…
